William C Stewart

Summary

Affiliation: Kathleen D. Schaum and Associates
Country: USA

Publications

  1. ncbi request reprint Corneal thickness after refractive surgery
    William C Stewart
    Ophthalmology 112:1637. 2005
  2. doi request reprint Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
    Barbara Cvenkel
    University Eye Clinic Ljubljana, Ljubljana, Slovenia
    Curr Eye Res 33:163-8. 2008
  3. ncbi request reprint Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects
    William C Stewart
    Pharmaceutical Research Network, Charleston, SC 29412 2464, USA
    J Glaucoma 12:475-9. 2003
  4. ncbi request reprint Dropout rates for intent-to-treat and per protocol analyses
    William C Stewart
    Pharaceutical Research Network, and Carolina Eye Institute, University of South Carolina School of Medicine, Columbia, South Carolina 29412 2464, USA
    Am J Ophthalmol 137:639-45. 2004
  5. ncbi request reprint Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
    W C Stewart
    Pharmaceutical Research Network LLC, Charleston, SC 29412, USA
    Eye (Lond) 18:990-5. 2004
  6. ncbi request reprint Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
    W C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29412 2464, USA
    Eye (Lond) 18:905-10. 2004
  7. ncbi request reprint Can patients guess their intraocular pressure?
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina 29412 2464, USA
    Am J Ophthalmol 137:350-1. 2004
  8. ncbi request reprint Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29412 2464, USA
    Arch Ophthalmol 121:1543-7. 2003
  9. ncbi request reprint Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina 29412 2464, USA
    Acta Ophthalmol Scand 81:242-6. 2003
  10. ncbi request reprint Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, South Carolina 29412 2464, USA
    J Glaucoma 12:151-5. 2003

Collaborators

Detail Information

Publications59

  1. ncbi request reprint Corneal thickness after refractive surgery
    William C Stewart
    Ophthalmology 112:1637. 2005
  2. doi request reprint Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
    Barbara Cvenkel
    University Eye Clinic Ljubljana, Ljubljana, Slovenia
    Curr Eye Res 33:163-8. 2008
    ..The efficacy of dorzolamide/timolol fixed combination (DTFC) versus latanoprost/timolol fixed combination (LTFC) in open-angle glaucoma or ocular hypertensive patients...
  3. ncbi request reprint Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects
    William C Stewart
    Pharmaceutical Research Network, Charleston, SC 29412 2464, USA
    J Glaucoma 12:475-9. 2003
    ..To evaluate short-term conjunctival and corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy individuals...
  4. ncbi request reprint Dropout rates for intent-to-treat and per protocol analyses
    William C Stewart
    Pharaceutical Research Network, and Carolina Eye Institute, University of South Carolina School of Medicine, Columbia, South Carolina 29412 2464, USA
    Am J Ophthalmol 137:639-45. 2004
    ..To describe dropout rates for the intent-to-treat and per protocol analyses from prospective clinical trials...
  5. ncbi request reprint Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
    W C Stewart
    Pharmaceutical Research Network LLC, Charleston, SC 29412, USA
    Eye (Lond) 18:990-5. 2004
    ....
  6. ncbi request reprint Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
    W C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29412 2464, USA
    Eye (Lond) 18:905-10. 2004
    ..To compare ocular tolerability of dorzolamide 2%, brinzolamide 1%, and placebo given three times daily...
  7. ncbi request reprint Can patients guess their intraocular pressure?
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina 29412 2464, USA
    Am J Ophthalmol 137:350-1. 2004
    ..To determine whether patients can guess their intraocular pressure (IOP)...
  8. ncbi request reprint Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29412 2464, USA
    Arch Ophthalmol 121:1543-7. 2003
    ....
  9. ncbi request reprint Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina 29412 2464, USA
    Acta Ophthalmol Scand 81:242-6. 2003
    ....
  10. ncbi request reprint Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, South Carolina 29412 2464, USA
    J Glaucoma 12:151-5. 2003
    ..To characterize and compare the ocular comfort and symptoms of dorzolamide and tear-replacement drops (placebo) in healthy volunteers...
  11. ncbi request reprint Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, SC 29412 2464, USA
    J Ocul Pharmacol Ther 18:211-20. 2002
    ..Evaluate the safety and efficacy of dorzolamide versus acetazolamide when added to once daily 0.5% timolol maleate ophthalmic gel forming solution (timolol gel)...
  12. ncbi request reprint Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Dallas, Texas, USA
    Ophthalmology 115:1117-1122.e1. 2008
    ....
  13. ncbi request reprint Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    Douglas G Day
    Omni Eye Services, LLC, Atlanta, Georgia, USA
    Am J Ophthalmol 135:138-43. 2003
    ..To compare the efficacy and safety of timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily...
  14. ncbi request reprint Ophthalmologist attitudes regarding fixed combination treatment for glaucoma in the European Union
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Dallas, TX, USA
    Eur J Ophthalmol 19:588-93. 2009
    ..To survey ophthalmologists in the European Union to determine their fixed combination (FC) preferences...
  15. ncbi request reprint Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, South Carolina, USA
    Acta Ophthalmol Scand 80:277-81. 2002
    ..To examine the influence on maximal exercise performance in young healthy volunteers of timolol 0.5%, brimonidine 0.2% or placebo versus brimonidine 0.2% and timolol 0.5% used concomitantly...
  16. ncbi request reprint Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, South Carolina 29412 2464, USA
    Am J Ophthalmol 135:314-20. 2003
    ..To evaluate conjunctival hyperemia after short-term use of latanoprost 0.005%, bimatoprost 0.03% and travoprost 0.004% in normal adults...
  17. ncbi request reprint The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina 29412 2464, USA
    Acta Ophthalmol Scand 82:161-5. 2004
    ..To compare the efficacy and safety of unoprostone versus brimonidine both given twice daily in ocular hypertensive or primary open-angle glaucoma subjects...
  18. ncbi request reprint The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%
    William C Stewart
    Pharmaceutical Research Corporation, Charleston, SC 29412, USA
    Curr Eye Res 24:387-91. 2002
    ..To evaluate the efficacy and safety of timolol maleate 0.5% gel forming solution (TXE, Merck) versus timolol maleate 0.5% gel forming solution (TXG, Falcon) in primary open-angle glaucoma and ocular hypertension patients...
  19. ncbi request reprint Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies
    Andreas Bayer
    Pharmaceutical Research Network, LLC, Charleston, SC, USA
    J Ocul Pharmacol Ther 20:470-8. 2004
    ..The aim of this study was to evaluate the long-term follow-up of patients who were changed to latanoprost from previous glaucoma therapies...
  20. doi request reprint Lower limits of intraocular pressure in glaucoma clinical trials
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Cheyenne, WY University of Nevada Las Vegas, Las Vegas, NV Medical University of South Carolina, Charleston, SC
    J Glaucoma 23:e105-7. 2014
    ..To determine the association of the lower limit of intraocular pressure (IOP) specified in the inclusion criteria to baseline and active treatment visit IOPs for monotherapy treatments...
  21. doi request reprint Risk factors for subject withdrawals in clinical trials evaluating glaucoma medications
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Charleston, SC, USA
    Graefes Arch Clin Exp Ophthalmol 248:1007-12. 2010
    ..To evaluate risk factors for subject withdrawals from multicenter clinical trials evaluating glaucoma medications...
  22. ncbi request reprint Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29407, USA
    J Ocul Pharmacol Ther 22:26-33. 2006
    ..The aim of this study was to evaluate the association of corneal thickness on the incidence of glaucomatous progression at individual levels of intraocular pressure...
  23. ncbi request reprint Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test
    William C Stewart
    Pharmaceutical Research Corp, Charleston, South Carolina, USA
    Acta Ophthalmol Scand 80:272-6. 2002
    ..To compare the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test...
  24. doi request reprint Cost-effectiveness of treating ocular hypertension
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Charleston, South Carolina, USA
    Ophthalmology 115:94-8. 2008
    ..To assess the cost-effectiveness of treating ocular hypertension (OHT) in the United States...
  25. doi request reprint Ocular surface disease in patients with ocular hypertension and glaucoma
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Charleston, South Carolina, USA
    Curr Eye Res 36:391-8. 2011
    ..To review the prevalence, diagnosis, causes, and treatment of ocular surface disease (OSD) in patients with ocular hypertension or primary open-angle glaucoma...
  26. ncbi request reprint Meta-analysis of articles evaluating routine intraocular pressure control in monotherapy in the United States and Germany
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Dallas, TX, USA
    Eur J Ophthalmol 19:769-75. 2009
    ..To evaluate routine intraocular pressure (IOP) control in monotherapy patients in the United States and Germany...
  27. doi request reprint Association of strength of religious adherence with attitudes regarding glaucoma or ocular hypertension
    William C Stewart
    PRN Pharmaceutical Research Network LLC, Charleston, SC 29406, USA
    Ophthalmic Res 45:53-6. 2011
    ..To evaluate the impact of religious adherence on a patient's outlook on disease in a glaucoma population...
  28. doi request reprint Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials
    R Allan Sharpe
    Medical University of South Carolina, Charleston, South Carolina, USA
    Br J Ophthalmol 97:121-5. 2013
    ..02). This study suggests that in early phase glaucoma trials, using the reduction from untreated baseline in general better approximates the results of later regulatory and post-commercialisation trials than the decrease from placebo...
  29. doi request reprint Predictive value of the efficacy of glaucoma medications in animal models: preclinical to regulatory studies
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, South Carolina, USA
    Br J Ophthalmol 95:1355-60. 2011
    ....
  30. ncbi request reprint Incidence of conjunctival exposure following drainage device implantation in patients with glaucoma
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Dallas, TX, USA
    Eur J Ophthalmol 20:124-30. 2010
    ..To evaluate prior studies including a glaucoma drainage device and to describe the timing and incidence of conjunctival exposure. A meta-analysis of previously published articles...
  31. doi request reprint Description of Ophthalmic Pharmaceutical and Device Start-Up Companies
    R Allan Sharpe
    Medical University of South Carolina, Charleston, S C, USA
    Ophthalmic Res 54:6-9. 2015
    ..To describe the number, type and location of ophthalmic companies and their associated product areas and indications...
  32. pmc Ocular blood flow in glaucoma: the need for further clinical evidence and patient outcomes research
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Charleston, SC, USA
    Br J Ophthalmol 91:1263-4. 2007
  33. doi request reprint Techniques to Reduce the Placebo Effect in Glaucoma Clinical Trials
    R Allan Sharpe
    Medical University of South Carolina, Charleston, SC, USA
    Ophthalmic Res 54:3-5. 2015
    ..To evaluate techniques used to reduce the placebo effect in prior well-controlled, single or double-masked placebo-controlled glaucoma trials...
  34. ncbi request reprint Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment
    William C Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC 29412 2464, USA
    J Ocul Pharmacol Ther 20:461-9. 2004
    ..The aim of this study was to identify research avenues that might improve patient compliance with glaucoma therapy...
  35. doi request reprint Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens
    William C Stewart
    PRN Pharmaceutical Research Network, LLC, Charleston, South Carolina, USA
    Am J Ophthalmol 150:744-751.e2. 2010
    ..To evaluate the ocular pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor in subjects undergoing cataract surgery...
  36. doi request reprint Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy
    Ivan Goldberg
    Sydney Eye Hospital, Glaucoma Services, Sydney, New South Wales, Australia
    J Glaucoma 21:55-9. 2012
    ..To compare the efficacy of brinzolamide versus placebo when added to travoprost/timolol fixed combination (TTFC) in uncontrolled patients...
  37. ncbi request reprint A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension
    Douglas G Day
    Atlanta Research Company, Atlanta, GA, USA
    J Ocul Pharmacol Ther 20:383-92. 2004
    ..The aim of this study was to evaluate differences in the persistency and treatment costs for latanoprost, bimatoprost, or beta-blockers in open-angle glaucoma or ocular hypertensive patients...
  38. ncbi request reprint Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies
    Anastasios G P Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    J Ocul Pharmacol Ther 20:375-82. 2004
    ..The aim of this study was to evaluate the efficacy and safety in ocular hypertensive or open-angle glaucoma patients changed to a latanoprost/timolol fixed combination (LTFC) from previous therapy...
  39. ncbi request reprint Factors associated with long-term progression or stability in exfoliation glaucoma
    Anastasios G P Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Arch Ophthalmol 122:29-33. 2004
    ..To evaluate the effect of intraocular pressure (IOP) reduction on long-term progression or stability in patients with exfoliation glaucoma...
  40. ncbi request reprint Letter to the editor: patient persistency with glaucoma therapy
    Richard Fiscella
    J Ocul Pharmacol Ther 21:349-50; author reply 350-2. 2005
  41. ncbi request reprint 24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma
    Anastasios G P Konstas
    Glaucoma Unit, Department of Ophthalmology, A University, AHEPA Hospital, Thessaloniki, Greece
    Ophthalmology 113:446-50. 2006
    ..To evaluate the quality of 24-hour intraocular pressure (IOP) control between morning- and evening-dosed travoprost in primary open-angle glaucoma patients...
  42. ncbi request reprint A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol
    Anastasios G P Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Am J Ophthalmol 133:753-7. 2002
    ..To evaluate morning vs evening once daily concomitant latanoprost 0.005%/timolol maleate 0.5% therapy in ocular hypertensive or primary open-angle glaucoma patients...
  43. ncbi request reprint Intraocular pressure, safety, and quality of life in glaucoma patients switching to latanoprost from monotherapy treatments
    Thom J Zimmerman
    University of Louisville, Louisville, KY, USA
    J Ocul Pharmacol Ther 19:405-15. 2003
    ..To evaluate the efficacy, safety and quality of life in ocular hypertensive or open-angle glaucoma patients who required alteration in previous therapy and were changed to latanoprost...
  44. ncbi request reprint Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination
    Anastasios G P Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Ophthalmology 110:1357-60. 2003
    ..005% given every evening versus timolol 0.5% and dorzolamide 2% fixed combination (TDFC) given twice daily to white Greeks with primary open-angle glaucoma and ocular hypertensive patients...
  45. ncbi request reprint Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients
    Jakub J Kałuzny
    Klinika Okulistyki, Bydgoszcz, Poland
    Acta Ophthalmol Scand 81:349-54. 2003
    ....
  46. ncbi request reprint An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension
    William C Stewart
    Am J Manag Care 8:S240-8. 2002
    ..The cost of treatment may become expensive, especially with multiple drug therapy. Thus, prescribing techniques that help minimize costs may be beneficial to patients when medically appropriate...
  47. ncbi request reprint Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients
    Anastasios G P Konstas
    Glaucoma Unit, University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Ophthalmology 112:262-6. 2005
    ..To evaluate latanoprost versus bimatoprost given each evening over the 24-hour diurnal curve...
  48. ncbi request reprint 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects
    Anastasios G P Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Ophthalmology 112:603-8. 2005
    ..To evaluate the 24-hour efficacy of brimonidine purite versus dorzolamide, each added to latanoprost...
  49. ncbi request reprint 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma
    Anastasios G P Konstas
    Glaucoma Unit, University Department of Ophthalmology, Australasian Hellenic Educational Progressive Association Hospital, Thessaloniki, Greece
    Ophthalmology 113:761-5.e1. 2006
    ..The purpose of this study was to evaluate 24-hour intraocular pressure (IOP) control in patients with moderate to severe open-angle glaucoma treated by trabeculectomy and mitomycin C versus maximum tolerated medical therapy...
  50. ncbi request reprint 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone
    Anastasios G P Konstas
    Glaucoma Unit, A University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Arch Ophthalmol 124:1553-7. 2006
    ..To evaluate 24-hour intraocular pressure (IOP) control with an evening-dosed latanoprost-timolol maleate fixed combination vs timolol alone in patients with primary open-angle glaucoma...
  51. ncbi request reprint Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients
    Anastasios G P Konstas
    Glaucoma Unit, Department of Ophthalmology, A University, Thessaloniki, Greece
    Ophthalmology 114:653-7. 2007
    ..To evaluate 24-hour intraocular pressure (IOP) efficacy of latanoprost versus travoprost, each given every evening, in exfoliative glaucoma patients...
  52. ncbi request reprint Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension
    Paul Harasymowycz
    Montreal Glaucoma Institute, Maaisonneuve Rosemont Hospital, University of Montreal, Quebec, Canada
    Can J Ophthalmol 42:75-81. 2007
    ..To compare the efficacy and safety of latanoprost and timolol gel-forming solution (GFS)...
  53. ncbi request reprint Midterm response with latanoprost therapy in german ocular hypertension patients
    Ulrich Thelen
    Curr Eye Res 32:51-6. 2007
    ..The purpose of this prospective observational trial was to report the analysis of the midterm efficacy, safety, and discontinuation rates of a cohort of ocular hypertensive patients treated with latanoprost in Germany...
  54. ncbi request reprint Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany
    Ulrich Thelen
    J Ocul Pharmacol Ther 23:311-3. 2007
    ..The aim of this analysis was to evaluate the general ophthalmologist's experience in using latanoprost to treat normal tension glaucoma (NTG) patients...
  55. ncbi request reprint Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy
    Sriram Sonty
    MidWest Eye Center, Calumet City, Illinois, USA
    Acta Ophthalmol 86:419-23. 2008
    ..We aimed to investigate the safety and efficacy of dorzolamide/timolol fixed combination (DTFC) in timolol responders with ocular hypertension or open-angle glaucoma who switched to DTFC because of insufficient control on latanoprost...
  56. ncbi request reprint The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy
    Elizabeth D Sharpe
    Glaucoma Consultants and Center For Eye Research, Mount Pleasant, South Carolina, USA
    Curr Eye Res 32:1037-43. 2007
    ..To evaluate the incidence and characteristics of periocular pigmentation with latanoprost versus bimatoprost...
  57. ncbi request reprint Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy
    Anastasios G P Konstas
    Glaucoma Unit, University Department of Ophthalmology, Australasian Hellenic Educational Progressive Association Hospital, Thessaloniki, Greece
    Arch Ophthalmol 123:898-902. 2005
    ..To evaluate the 24-hour efficacy and safety of the latanoprost-timolol maleate-fixed combination vs latanoprost therapy in patients with primary open-angle glaucoma...
  58. doi request reprint Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment
    Anastasios G P Konstas
    Glaucoma Unit, First University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
    Ophthalmology 115:99-103. 2008
    ..To evaluate the 24-hour intraocular pressure (IOP)-lowering effect of latanoprost and the dorzolamide/timolol fixed combination (DTFC) after 2 and 6 months of treatment...
  59. ncbi request reprint The benefit of repeated intraocular pressure measurements in clinical trials
    William C Stewart
    Arch Ophthalmol 122:936-7. 2004